Jane A Gross Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jane A Gross.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jane A Gross. Jane A Gross is Director in aTYR PHARMA INC ($LIFE) and See Remarks in Aptevo Therapeutics Inc. ($APVO) and SVP & Chief Scientific Officer in Aptevo Therapeutics Inc. ($APVO).
Latest Insider Trading Transactions of Jane A Gross
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2021 | LIFE | aTYR PHARMA INC | Gross Jane A | Director | Option Exercise | A | 4.21 | 1,428 | 6,012 | 1,428 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 0.00 | 5,500 | 0 | 5,500 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 33.50 | 16,500 | 552,750 | 16,500 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 7,784 | 66,631 | 7,784 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 7,784 | 66,631 | 7,784 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 41.58 | 3,908 | 162,495 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 35.70 | 2,779 | 99,210 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 41.58 | 3,908 | 162,495 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 34.58 | 2,072 | 71,650 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 35.70 | 2,779 | 99,210 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 34.58 | 2,072 | 71,650 | 0 | |
| May 08 2020 | LIFE | aTYR PHARMA INC | Gross Jane A | Director | Option Exercise | A | 3.65 | 1,428 | 5,212 | 1,428 | |
| Mar 19 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 0.50 | 134,800 | 67,130 | 134,800 | |
| Nov 05 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 0.58 | 122,982 | 70,838 | 122,982 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,138 | 0 | 0 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 1.52 | 67,400 | 102,448 | 67,400 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.57 | 2,710 | 4,255 | 109,583 | 112.3 K to 109.6 K (-2.41 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,138 | 0 | 112,293 | 103.2 K to 112.3 K (+8.86 %) |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,728 | 0 | 9,138 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 3.13 | 67,400 | 210,962 | 67,400 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 3.13 | 2,282 | 7,143 | 103,155 | 105.4 K to 103.2 K (-2.16 %) |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,728 | 0 | 105,437 | 95.7 K to 105.4 K (+10.16 %) |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,140 | 0 | 18,866 | |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,140 | 0 | 95,709 | 86.6 K to 95.7 K (+10.56 %) |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 18,136 | 0 | 28,006 | |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 18,136 | 0 | 86,569 | 68.4 K to 86.6 K (+26.50 %) |
| Aug 03 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 38,093 | 0 | 46,142 | |
| Aug 03 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.83 | 10,076 | 18,439 | 68,433 | 78.5 K to 68.4 K (-12.83 %) |
| Aug 03 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 38,093 | 0 | 78,509 | 40.4 K to 78.5 K (+94.25 %) |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 2.15 | 33,700 | 72,455 | 33,700 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 14,506 | 0 | 84,235 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,727 | 0 | 98,741 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,140 | 0 | 108,468 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.78 | 3,837 | 6,830 | 40,416 | 44.3 K to 40.4 K (-8.67 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 14,506 | 0 | 44,253 | 29.7 K to 44.3 K (+48.76 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.80 | 2,573 | 4,631 | 29,747 | 32.3 K to 29.7 K (-7.96 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,727 | 0 | 32,320 | 22.6 K to 32.3 K (+43.05 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 2.02 | 2,148 | 4,339 | 22,593 | 24.7 K to 22.6 K (-8.68 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,140 | 0 | 25,011 | 15.9 K to 25 K (+57.59 %) |
| Feb 27 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 1.96 | 33,700 | 66,052 | 156,339 | |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 18,135 | 0 | 117,608 | |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.92 | 5,922 | 11,370 | 15,871 | 21.8 K to 15.9 K (-27.17 %) |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 18,135 | 0 | 21,793 | 3.7 K to 21.8 K (+495.76 %) |
Page: 1